Posted on

AstraZeneca (formerly BMS, Amylin Ohio) develops and produces pharmaceuticals for the treatment of diabetes, including a long-acting release formulation of exenatide, which is being developed to treat Type-2 diabetes. AstraZeneca is also currently involved in the clinical development of pharmaceuticals for neurohormonal therapy for obesity.